KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195,128 | -18.0% | 7,068 | +5.1% | 0.01% | -9.1% |
| Q2 2023 | $1,457,882 | +16.1% | 6,723 | -2.7% | 0.01% | 0.0% |
| Q1 2023 | $1,255,314 | -42.4% | 6,911 | -37.7% | 0.01% | -42.1% |
| Q4 2022 | $2,180,561 | +7.0% | 11,097 | +22.5% | 0.02% | 0.0% |
| Q3 2022 | $2,038,000 | +69.7% | 9,062 | -4.6% | 0.02% | +111.1% |
| Q2 2022 | $1,201,000 | -5.9% | 9,495 | -5.7% | 0.01% | +12.5% |
| Q1 2022 | $1,276,000 | +2.3% | 10,070 | +5.8% | 0.01% | +14.3% |
| Q4 2021 | $1,247,000 | +11.9% | 9,521 | +4.5% | 0.01% | 0.0% |
| Q3 2021 | $1,114,000 | +4.8% | 9,109 | -2.3% | 0.01% | +16.7% |
| Q2 2021 | $1,063,000 | -0.6% | 9,321 | +4.8% | 0.01% | -14.3% |
| Q1 2021 | $1,069,000 | +126.0% | 8,895 | +91.2% | 0.01% | +133.3% |
| Q4 2020 | $473,000 | – | 4,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |